Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers
Authors:
- Manal F. ElshamaaMEManal F. Elshamaa
- Safaa M. Abdel-RahmanSASafaa M. Abdel-Rahman
- Eman H. ThabetETEman H. Thabet
- Solaf KamelSKSolaf Kamel
- Dina KandilDKDina Kandil
- Mona H. IbrahimMIMona H. Ibrahim
- Mostafa El-AhmadyMEMostafa El-Ahmady
- 1 March 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 27 (2) , 190-198
Abstract
This study aimed to assess whether markers of coagulation, fibrinolysis or thrombophilia are increased in children on haemodialysis compared with controls and whether measurement of any of these factors could help to identify patients at an increased risk of arteriovenous fistula (AVF) occlusion. Blood samples were taken from 55 children immediately before a session of haemodialysis and from 20 healthy volunteers. Thrombin–antithrombin (TAT), D-dimer, plasmin–antiplasmin (PAP) and anticardiolipin immunoglobulin G (ACA-Ig G) were measured by ELISA. Factor V Leiden mutation (G1691A) was determined by gene polymorphism [restriction fragment length polymorphism (RFLP)]. Determination of the patency of the AVF was prospectively followed up for a minimum of 4 years or until the AVF was nonfunctioning. Fifty-five patients were studied with a median follow-up of 659 days (range 30–1670 days). A significant increase was found in the levels of D-dimer, PAP and ACA-Ig G in haemodialysis patients with thrombosed and nonthrombosed native AVFs vs. controls. There was a significant difference between both chronic haemodialysis patients with thrombosed and nonthrombosed native AVF with regard to ACA-IgG levels. At 1 year follow-up, primary patency was 61.4% (27 patients). In multivariate analysis, D-dimer was inversely associated with secondary patency. Thrombophilia may predispose children with end stage renal disease to access failure. The promising finding is that in children on haemodialysis, D-dimer levels were increased and inversely correlated with secondary patency. Further evaluation is required into the possible role of D-dimer as a biomarker of AVF occlusion.Keywords
This publication has 46 references indexed in Scilit:
- Thrombin-Anti-Thrombin Levels and Patency of Arterio-Venous Fistula in Patients Undergoing Haemodialysis Compared to Healthy Volunteers: A Prospective AnalysisPLOS ONE, 2013
- Thrombophilia and Arteriovenous Fistula Survival in ESRDClinical Journal of the American Society of Nephrology, 2013
- Role of Thrombophilia in Vascular Access Thrombosis Among Chronic Hemodialysis Patients in TunisiaTherapeutic Apheresis and Dialysis, 2011
- Hemodialysis Arteriovenous Fistula Patency RevisitedClinical Journal of the American Society of Nephrology, 2008
- Platelet (Dys)function and Plasma Plasminogen Levels in Hemodialysis PatientsTherapeutic Apheresis and Dialysis, 2008
- Interleukin-10 and Tumor Necrosis Factor-α Polymorphisms in Vascular Access Failure in Patients on Hemodialysis: Preliminary Data in KoreaJournal of Korean Medical Science, 2008
- Risk factors for thromboembolic events in renal failureInternational Journal of Cardiology, 2005
- Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosisInternational Journal Of Clinical Practice, 2005
- Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor-α Gene Polymorphism in Patients with End-Stage Renal FailureRenal Failure, 2005
- Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistulaNephrology Dialysis Transplantation, 1996